Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GIST, Malignant”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Testing effectiveness (Phase 2)Study completedNCT01294202
What this trial is testing

Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Astex Pharmaceuticals, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT01154452
What this trial is testing

Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
Adult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+32 more
National Cancer Institute (NCI) 78
Not applicableUnknownNCT04927260
What this trial is testing

French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients

Who this might be right for
GISTGIST, MalignantPDGFR-Alpha D842V
Centre Leon Berard 25
Testing effectiveness (Phase 2)Study completedNCT00400569
What this trial is testing

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

Who this might be right for
LiposarcomaLeiomyosarcomaFibrosarcoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 48
Post-approval studies (Phase 4)Study completedNCT00793871
What this trial is testing

Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors
Pfizer 60
Testing effectiveness (Phase 2)Looking for participantsNCT07169344
What this trial is testing

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma (Excluding GIST)Soft Tissue Sarcoma AdultSoft Tissue Sarcoma of the Trunk and Extremities+6 more
Oslo University Hospital 110
Testing effectiveness (Phase 2)UnknownNCT02982486
What this trial is testing

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Who this might be right for
Soft Tissue SarcomaBone SarcomaChondrosarcoma+5 more
Assaf-Harofeh Medical Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390826
What this trial is testing

Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 10
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableStudy completedNCT06038552
What this trial is testing

Comparison of Clinical Efficacy of Liver Resection, RFA, TACE, and Drug Therapy in Patients with GIST LM

Who this might be right for
GIST, MalignantLiver Metastases
First Affiliated Hospital, Sun Yat-Sen University 238
Not applicableLooking for participantsNCT05461664
What this trial is testing

Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA

Who this might be right for
Gastrointestinal Stromal TumorsUnresectable Solid TumorRecurrent Metastatic Malignant Neoplasm
Xinhua Zhang, MD 74
Testing effectiveness (Phase 2)UnknownNCT03171389
What this trial is testing

POETIG Trial - POnatinib After rEsisTance to Imatinib in GIST

Who this might be right for
GIST, MalignantKIT Exon 13 MutationKIT Gene Mutation
Sebastian Bauer 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Not applicableUnknownNCT03381053
What this trial is testing

Study to Compare Pathologic Type, NIH and WHO Criteria,and Mechanism of GIST Malignant Transformation

Who this might be right for
Method of Differentiating Benignancy and Malignancy, Grading and Staging for GIST
Shanghai Zhongshan Hospital 3,000
Early research (Phase 1)Study completedNCT01376505
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Solid Tumors

Who this might be right for
Malignant Solid TumourBreast CancerMalignant Tumor of Colon+2 more
Robert Wesolowski 65
Early research (Phase 1)Study completedNCT01046487
What this trial is testing

Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate

Who this might be right for
Cancer
Centre Oscar Lambret 26
Not applicableUnknownNCT04143048
What this trial is testing

A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules

Who this might be right for
Gastrointestinal Stromal Tumor
The First Affiliated Hospital with Nanjing Medical University 300
Early research (Phase 1)Looking for participantsNCT06655246
What this trial is testing

Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)Gastrointestinal Stromal CancerGastrointestinal Stromal Neoplasm+2 more
Kura Oncology, Inc. 157
Load More Results